The controversial role of mast cells in fibrosis
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Summary: Fibrosis is a medical condition characterized by an excessive deposition of extracellular matrix compounds such as collagen in tissues. Fibrotic lesions are present in many diseases and can affect all organs. The excessive extracellular matrix accumulation in these conditions can often have serious consequences and in many cases be life‐threatening. A typical event seen in many fibrotic conditions is a profound accumulation of mast cells (MCs), suggesting that these cells can contribute to the pathology. Indeed, there is now substantialv evidence pointing to an important role of MC s in fibrotic disease. However, investigations from various clinical settings and different animal models have arrived at partly contradictory conclusions as to how MC s affect fibrosis, with many studies suggesting a detrimental role of MC s whereas others suggest that MC s can be protective. Here, we review the current knowledge of how MC s can affect fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Costabel, U., Cottin, V., Flaherty, K. R., Hansell, D. M., Inoue, Y., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402584 · Cited by 4,654
Cellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
Webster, A. C., Nagler, E. V., Morton, R. L., & Masson, P. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32064-5 · Cited by 3,842
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Wynn, T. A., & Ramalingam, T. R. (2012) · Nature Medicine · doi:10.1038/nm.2807 · Cited by 3,541
Yayon, A., Klagsbrun, M., Esko, J. D., Leder, P., & Ornitz, D. M. (1991) · Cell · doi:10.1016/0092-8674(91)90512-w · Cited by 2,440
King, T. E., Pardo, A., & Selman, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60052-4 · Cited by 2,194
Pathogenesis of Liver Fibrosis
Hernandez-Gea, V., & Friedman, S. L. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130246 · Cited by 1,809
Incidence and Prevalence of Idiopathic Pulmonary Fibrosis
Raghu, G., Weycker, D., Edelsberg, J., Bradford, W. Z., & Oster, G. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200602-163oc · Cited by 1,310
Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis
Wollin, L., Wex, E., Pautsch, A., Schnapp, G., Hostettler, K. E., Stowasser, S., & Kolb, M. (2015) · European Respiratory Journal · doi:10.1183/09031936.00174914 · Cited by 1,005
Heparin protects basic and acidic FGF from inactivation
Gospodarowicz, D., & Cheng, J. (1986) · Journal of Cellular Physiology · doi:10.1002/jcp.1041280317 · Cited by 853
Postlethwaite, A. E., Holness, M. A., Katai, H., & Raghow, R. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116015 · Cited by 504
Pawankar, R., Okuda, M., Yssel, H., Okumura, K., & Ra, C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119311 · Cited by 340
Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts
Cairns, J. A., & Walls, A. F. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119290 · Cited by 318
Fairweather, D., Frisancho-Kiss, S., Yusung, S. A., Barrett, M. A., Davis, S. E., Gatewood, S. J. L., Njoku, D. B., & Rose, N. R. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63241-5 · Cited by 198
Pericellulars substrates of human mast cell tryptase: 72,000 Dalton gelatinase and fibronectin
Lohi, J., Kesksi‐Oja, J., & Harvima, I. (1992) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240500402 · Cited by 182
The differentiation and function of myofibroblasts is regulated by mast cell mediators
Gailit, J., Marchese, M. J., Kew, R. R., & Gruber, B. L. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.15211.x · Cited by 174
Effect of histamine on proliferation of normal human adult lung fibroblasts
Jordana, M., Befus, A. D., Newhouse, M. T., Bienenstock, J., & Gauldie, J. (1988) · Thorax · doi:10.1136/thx.43.7.552 · Cited by 113
Cameron, L., Hamid, Q., Wright, E., Nakamura, Y., Christodoulopoulos, P., Muro, S., Frenkiel, S., Lavigne, F., Durham, S., & Gould, H. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.107398 · Cited by 107
FcϵRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells
Okayama, Y., Okumura, S., Sagara, H., Yuki, K., Sasaki, T., Watanabe, N., Fueki, M., Sugiyama, K., Takeda, K., Fukuda, T., et al. (2009) · European Respiratory Journal · doi:10.1183/09031936.00121008 · Cited by 100
Gallant‐Behm, C. L., Hildebrand, K. A., & Hart, D. A. (2008) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2008.00363.x · Cited by 98
Cited by
Pathological mechanisms and therapeutic outlooks for arthrofibrosis
Usher, K. M., Zhu, S., Mavropalias, G., Carrino, J. A., Zhao, J., & Xu, J. (2019) · Bone Research · doi:10.1038/s41413-019-0047-x · Cited by 285
Spagnolo, P., Distler, O., Ryerson, C. J., Tzouvelekis, A., Lee, J. S., Bonella, F., Bouros, D., Hoffmann-Vold, A.-M., Crestani, B., & Matteson, E. L. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217230 · Cited by 259
Type 3 cytokines IL-17A and IL-22 drive TGF-β–dependent liver fibrosis
Fabre, T., Molina, M. F., Soucy, G., Goulet, J.-P., Willems, B., Villeneuve, J.-P., Bilodeau, M., & Shoukry, N. H. (2018) · Science Immunology · doi:10.1126/sciimmunol.aar7754 · Cited by 155
“Neutrophils and mast cells are implicated in the progression of fibrosis in many organs due to their capacity to secrete profibrogenic factors such as reactive oxygen species, LOXL2 TGF-, and platelet-derived growth factor (37).”
BackgroundNew perspectives on the origins and heterogeneity of mast cells
St. John, A. L., Rathore, A. P. S., & Ginhoux, F. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00731-2 · Cited by 126
Kucharik, A. H., & Chang, C. (2020) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-019-08755-8 · Cited by 122
Metadata
- Authors
- Bradding, P., & Pejler, G.
- Venue
- Immunological Reviews
- Publisher
- Wiley
- Published
- 2018-02-12
- Volume
- 282
- Issue
- 1
- Pages
- 198-231
- ISSN
- 0105-2896 (ISSN-L)
- 1600-065X
- OpenAlex
- W2794231249
- Cited by
- 129
- References
- 20
- FWCI
- 1.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.